About iScribe
iScribe is a company based in San Mateo (United States) founded in 1999. iScribe has raised $17.1 million across 2 funding rounds from investors including Kleiner Perkins, Earlybird and Galen Partners. iScribe operates in a competitive market with competitors including DoseSpot, AssistRx, MedRunner Health Solutions, Prematics and Prescrypto, among others.
- Headquarter San Mateo, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.1 M (USD)
in 2 rounds
-
Latest Funding Round
$15 M (USD), Series D
Apr 17, 2001
-
Investors
Kleiner Perkins
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of iScribe
iScribe has successfully raised a total of $17.1M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $15 million completed in April 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in iScribe
iScribe has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Kleiner Perkins, Earlybird and Galen Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Earlybird is recognized as a venture capital investor focused on early-stage tech companies.
|
Locked | Locked | Locked | |
|
PE firm investing in the US
|
Locked | Locked | Locked | |
|
Life science & tech focused VC firm investing in the US
|
Locked | Locked | Locked |
Investor details for iScribe
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by iScribe
Investment portfolio details for iScribe
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - iScribe
Detailed financials for iScribe
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Iscribe Comparisons
Peer comparison for iScribe
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of iScribe
iScribe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DoseSpot, AssistRx, MedRunner Health Solutions, Prematics and Prescrypto, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
E-prescribing integration services are offered for healthcare platforms.
|
|
| Locked | Locked | Locked |
Patient-focused software solution for prescribing specialty medications
|
|
| Locked | Locked | Locked |
An ePrescription platform connects physicians directly to pharmacists.
|
|
| Locked | Locked | Locked |
Mobile based medication management and e-prescribe platform for health care providers
|
|
| Locked | Locked | Locked |
Electronic prescription platform is provided for healthcare providers.
|
Detailed competitors of iScribe
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Iscribe
Complete news archive for iScribe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about iScribe
iScribe was founded in 1999 and raised its 1st funding round 1 year after it was founded.
iScribe is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
David Levinson is the current CEO of iScribe.
iScribe is a funded company, having raised a total of $17.1M across 2 funding rounds to date.
iScribe was founded in 1999 in San Mateo, United States, as a healthcare technology company. Mobile, handheld, wireless electronic prescribing solutions were developed, including the Windows CE-based iScribe i3000 system, which utilized a Cassiopeia handheld device, prescription software, practice management interface, and wireless printer. Additionally, the Palm OS-based iScribe i5000 was created as a pocket-sized device for radio frequency or cellular communication to secure networks.
iScribe's top competitors include AssistRx, DoseSpot and Elemental Software.
iScribe has 5 investors. Key investors include Kleiner Perkins, Earlybird, Galen Partners, Domain Associates, and Skyline Ventures.